Sanofi and Regeneron’s Dupixent shows more encouraging results

Published 4y ago

PARIS (Reuters) – Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema. The companies said that Dupixent Phase 3 data showed a s... More »